You've built something valuable. We'll help you realize that value on your terms.
We provide liquidity to owner-founders while allowing them to preserve the legacy they have worked hard to build.
We strive to be the buyer of choice for privately held lower middle market companies
We bring deep operating experience across an array of industries including: pharma, med-tech, healthcare, consumer products, manufacturing, software, etc.
We are a compelling alternative to Private Equity or selling to a competitor - who may look to tie up the owner long term, or break up the business.
DOES THIS SOUND LIKE YOU?
If this describes your business, we'd love to have a conversation
COMPANY CHARACTERISTICS
-
Strong reputation and long-term customer relationships
-
Quality products or services with competitive differentiation
-
Profitable with positive margin momentum
-
Growing revenue in a fragmented industry
-
Low customer concentration
-
Owner-founder led with 10+ years in business
$500K - $3 M
EBITDA Target
Not a perfect fit? We are flexible - if you're in the ballpark, let's talk
$2M - $25M
Revenue Target
TARGET INDUSTRIES
-
Medical Products & Devices
-
Pharmaceutical Products
-
Wellness Products
-
Care Management
-
Specialty B2B Services
-
Specialty Products
-
Software Products & Services
WHAT MAKES VIE CAPITAL PARTNERS DIFFERENT?
People First
We cultivate a culture that respects snd develops employees. We protect what you've buiilt, not just the financials.
Stewards of the Brand
We understand the tremendous effort it takes to build a reputation and a name. The brand continues - we work to strengthen it and help it grow.
Flexible Approach & Structure
We can tailor acquisitions for tax efficiency, estate planning, timing, transition profile, lifestyle, and other owner objectives.
Long Term Horizon
We make long-term investments in growth-oriented businesses and act as a catalyst for sustained value creation.
vs. Competitors and Private Equity
Unlike PE firms or Competitors, we don't lock owners into performance-driven hurdles and long term contracts. We bring industry knowledge to complement the existing foundation. We don't look to cherry-pick assets or dismantle the business. We build on your success.
LEADERSHIP
Mike Wootton
Mike is co-founder and CEO of NF2 Therapeutics, an early stage biotechnology company. He was founding CEO of NFlection Therapeutics, a successful clinical stage biotechnology company. Mike was formerly a Partner, and Head of Life Sciences & Healthcare Sector at Celerant Consulting (acquired by Hitachi). Mike has worked across an array of industries including Biotechnology, Pharmaceuticals, Medical Device, Healthcare, Consumer Products, Manufacturing, Specialty Products, Professional Services, and Software. Mike has an MBA from the Harvard Business School, and a BASc, Mechanical Engineering (co-op) from the University of Waterloo.
“WHAT YOU BUILT MATTERS. A GREAT COMPANY DESERVES TO CONTINUE THRIVING.”